US Patent Issued to MOUNTAIN VALLEY MD on July 15 for "Cannabinoid monoterpene based pharmaceutical topical composition for musculoskeletal pain" (New Jersey Inventor)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,587, issued on July 15, was assigned to MOUNTAIN VALLEY MD INC. (Vaughan, Canada).

"Cannabinoid monoterpene based pharmaceutical topical composition for musculoskeletal pain" was invented by Michael Farber (Livingston, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A topical pain relief composition has a base with a mixture of various components such as, but not limited to, a base, d-limonene, cannabinoids or a derivative thereof, ashwagandha extracts and dimethyl sulfoxide (DMSO)."

The patent was filed on June 20, 2022, under Application No. 17/844,139.

*For further information, including images, charts and tables, please visit: http://patft...